CAI Caris Life Sciences Inc.

$CAI 18 SEP 26 $30 CALL $0.45 HIGH CONFIDENCE + RELATIVE STRENGTH + IPO PRICE BREAKOUT CONTINUATION + PRICE TARGET BY UBS

$CAI The institutions are going to collect the liquidity here by the end of the day. We will end the day above 24.30.

$CAI .. holy smokes! What a run this week over at Caris . I think we need one of their fancy Kevin Costner commercials over here at $LKNCY $RKLB $VELO and an especially ‘touching holiday version’ for my crippled lil tiny Tim ticker $BURU 💰😎👍

📊 TODAY’S TRADE SUMMARY 🔥 CLOSED / PARTIAL CLOSES 📈 $CAI 30C — +126% ✅ 📈 $COIN 190C — +180% 🔥 📈 $CLSK 14C — +240% 🏆 📈 $NVDA 220C — +16.3% ✅ 📈 $NVO 43C — +35.7% 🔥 📈 $TSLA 375C — +28.4% ✅ 🚀 WINNING UPDATES 📈 $SPCX 175C — +77% 👽 📈 $AAPL 342.5C — +46% 🍎 🔥 That’s how you wrap up the week, solid day overall, see you guys next week💯

WHO WANTS ANOTHER HIGH-CONFIDENCE TRADE LIKE $CAI $30 CALLS THAT JUST HIT 100% IN LESS THAN ONE HOUR?! ☢️🔥 100%+ GAINER AFTER 100%+ GAINER — THE SETUPS SPEAK FOR THEMSELVES. 📈 I’LL KEEP POSTING THE SETUPS. YOU DECIDE IF THEY’RE FOR YOU NO PRESSURE, JUST REAL TRADES, REAL RESULTS, AND DISCIPLINE. ☢️ LIKE THIS IF YOU WANT THE NEXT ONE. 👀

$CAI Mark Massaro increased his price target on Caris Life Sciences to $33 following strong Q2 2026 earnings, highlighted by 45% revenue growth, expanding gross margins, and positive free cash flow. His bullish outlook is further driven by rising adoption of the company's Caris Assure blood assay and the long-term monetization potential of its massive AI-driven biopharma dataset.

🧬 $CAI — 100% GAINER $30 CALL | 18 SEP 26 $0.45 ➡️ $0.90 💰 That’s a clean 100% move from entry. 📈 Another setup executed with discipline. No chasing — just following the plan. ⚠️ Options are high-risk. Manage your position size and risk.